PapersFlow Research Brief
Atherosclerosis and Cardiovascular Diseases
Research Guide
What is Atherosclerosis and Cardiovascular Diseases?
Atherosclerosis is an inflammatory disease driven by immune responses to modified lipids such as oxidized LDL, involving T cell activation, B cell responses, cytokines, dendritic cells, regulatory T cells, and the LOX-1 receptor, which contributes to the pathogenesis of cardiovascular diseases including coronary artery disease.
This field encompasses 48,763 papers examining immunological mechanisms in atherosclerosis development and progression. Key topics include inflammation, oxidized LDL, adaptive immunity, and immune cell roles such as dendritic cells and regulatory T cells. Research demonstrates that immune responses mediate all stages of atherosclerosis from initiation to plaque instability.
Topic Hierarchy
Research Sub-Topics
Oxidized LDL in Atherosclerosis
This sub-topic explores oxidized low-density lipoprotein uptake by macrophages via scavenger receptors and foam cell formation. Researchers investigate oxidation pathways, immunogenicity, and therapeutic targeting.
Regulatory T Cells in Atherosclerosis
This sub-topic examines Treg suppression of pro-inflammatory T cells in plaques and their role in plaque stability. Researchers study Treg recruitment, Foxp3 expression, and depletion models.
Cytokines in Atherosclerotic Inflammation
This sub-topic covers pro-atherogenic cytokines like IL-6, TNF-α, and IFN-γ secreted by plaque immune cells. Researchers profile cytokine networks, signaling cascades, and anti-cytokine therapies.
Dendritic Cells in Atherosclerosis
This sub-topic investigates dendritic cell maturation, antigen presentation to T cells, and migration in vascular inflammation. Researchers use DC depletion models to assess plaque progression.
LOX-1 Receptor in Atherosclerosis
This sub-topic focuses on lectin-like oxidized LDL receptor-1 mediating endothelial dysfunction and monocyte adhesion. Researchers explore LOX-1 signaling, polymorphisms, and antagonists.
Why It Matters
Immunological insights into atherosclerosis have informed therapies targeting inflammation to reduce cardiovascular events. "Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men" by Ridker et al. (1997) showed that baseline C-reactive protein levels predict myocardial infarction and stroke risk, with aspirin reducing risk proportional to these levels in men. "Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels" by Downs et al. (1998) demonstrated lovastatin lowers first acute coronary event risk in patients with average LDL-C and below-average HDL-C, supporting lipid-lowering for primary prevention. These findings link inflammation to clinical outcomes, guiding statin and anti-inflammatory interventions in cardiology.
Reading Guide
Where to Start
"Atherosclerosis — An Inflammatory Disease" by Ross (1999), as it provides the foundational shift viewing atherosclerosis as inflammation-driven, with 21,571 citations establishing core concepts like LDL's role in immune activation.
Key Papers Explained
"Atherosclerosis — An Inflammatory Disease" by Ross (1999) builds on earlier injury models in "The Pathogenesis of Atherosclerosis — An Update" by Ross (1986) and "The pathogenesis of atherosclerosis: a perspective for the 1990s" by Ross (1993), emphasizing inflammation. "Inflammation in atherosclerosis" by Libby (2002) and "Inflammation and Atherosclerosis" by Libby et al. (2002) extend this to immune mechanisms across stages. "Inflammation, Atherosclerosis, and Coronary Artery Disease" by Hansson (2005) connects to clinical coronary outcomes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Field centers on immunological details like oxidized LDL, LOX-1, T/B cell roles, and cytokines, per 48,763 papers. No recent preprints or news indicate steady focus on established mechanisms without new shifts.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Atherosclerosis — An Inflammatory Disease | 1999 | New England Journal of... | 21.6K | ✕ |
| 2 | The 1982 revised criteria for the classification of systemic l... | 1982 | Arthritis & Rheumatism | 14.5K | ✕ |
| 3 | The pathogenesis of atherosclerosis: a perspective for the 1990s | 1993 | Nature | 10.6K | ✕ |
| 4 | Inflammation, Atherosclerosis, and Coronary Artery Disease | 2005 | New England Journal of... | 8.6K | ✕ |
| 5 | Inflammation in atherosclerosis | 2002 | Nature | 8.0K | ✕ |
| 6 | Inflammation and Atherosclerosis | 2002 | Circulation | 7.6K | ✕ |
| 7 | Inflammation, Aspirin, and the Risk of Cardiovascular Disease ... | 1997 | New England Journal of... | 5.5K | ✓ |
| 8 | Primary Prevention of Acute Coronary Events With Lovastatin in... | 1998 | JAMA | 5.3K | ✕ |
| 9 | Derivation and validation of the Systemic Lupus International ... | 2012 | Arthritis & Rheumatism | 5.1K | ✓ |
| 10 | The Pathogenesis of Atherosclerosis — An Update | 1986 | New England Journal of... | 4.9K | ✕ |
Frequently Asked Questions
What defines atherosclerosis as an inflammatory disease?
Atherosclerosis involves an ongoing inflammatory response to high plasma LDL cholesterol, particularly oxidized LDL, initiating atherogenesis. "Atherosclerosis — An Inflammatory Disease" by Ross (1999) establishes inflammation as central, shifting views from passive lipid storage. Immune cells like T cells and dendritic cells drive plaque formation and progression.
How does inflammation contribute to coronary artery disease?
"Inflammation, Atherosclerosis, and Coronary Artery Disease" by Hansson (2005) summarizes inflammation's role in acute coronary syndromes pathogenesis. Adaptive immunity and cytokines promote plaque instability leading to thrombosis. This process links chronic immune activation to myocardial infarction.
What is the role of C-reactive protein in cardiovascular risk?
"Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men" by Ridker et al. (1997) found plasma C-reactive protein predicts future myocardial infarction and stroke. Aspirin reduces first infarction risk related to C-reactive protein levels. This marker reflects underlying inflammatory processes in atherosclerosis.
What are key immunological mechanisms in atherosclerosis?
Mechanisms include T cell activation, B cell responses, regulatory T cells, cytokines, dendritic cells, and LOX-1 receptor signaling to oxidized LDL. "Inflammation in atherosclerosis" by Libby (2002) details how these mediate disease stages. "Inflammation and Atherosclerosis" by Libby et al. (2002) confirms inflammation's fundamental role from initiation to thrombosis.
How have perspectives on atherosclerosis pathogenesis evolved?
"The pathogenesis of atherosclerosis: a perspective for the 1990s" by Ross (1993) and "The Pathogenesis of Atherosclerosis — An Update" by Ross (1986) outline inflammatory and immune contributions over decades. These works emphasize response-to-injury models involving endothelial dysfunction and leukocyte recruitment. Updates integrate adaptive immunity findings.
Open Research Questions
- ? How do specific cytokine profiles from dendritic cells influence plaque stability in advanced atherosclerosis?
- ? What is the precise role of LOX-1 receptor signaling in T cell activation during oxidized LDL uptake?
- ? Can regulatory T cell modulation halt progression from early foam cell formation to thrombotic complications?
- ? How do B cell responses interact with adaptive immunity to exacerbate or resolve inflammatory lesions?
- ? What thresholds of oxidized LDL trigger sustained immune responses leading to chronic inflammation?
Recent Trends
The field holds 48,763 papers with no specified 5-year growth rate.
Highly cited works from 1982-2012, such as Ross with 21,571 citations and Tan et al. (1982) with 14,548, reflect foundational inflammation and criteria establishment.
1999Absence of recent preprints or news points to consolidated knowledge on immune mechanisms.
Research Atherosclerosis and Cardiovascular Diseases with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Atherosclerosis and Cardiovascular Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers